Clinical Trial Update: PGE2 Levels in Patient Treated With NSAIDs [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on PGE2 levels in patients treated with NSAIDs for ocular inflammation. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation

Drugs mentioned

• NSAIDs (non-steroidal anti-inflammatory drugs)

Snippet

Sponsor: University of Trieste | Conditions: Ocular Inflammation | Phase 3 | Status: COMPLETED